Healthcare Services

Fibromyalgia Treatment Market Revenue Anticipated To Reach $3.66 Billion By 2030 With 5% CAGR

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Fibromyalgia Treatment Market Progress Through 2030?

The size of the fibromyalgia treatment market has experienced continuous growth over recent years. It is projected to expand from $2.89 billion in 2025 to $3.01 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.2%. Historically, this expansion has been driven by factors such as a rise in the diagnosis of chronic pain disorders, the availability of antidepressants and antiepileptics, enhanced healthcare access, the proliferation of pain clinics, and improved awareness of the disease.

The fibromyalgia treatment market size is expected to see strong growth in the next few years. It will grow to $3.67 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to development of targeted pain therapies, growth in personalized treatment plans, increased adoption of digital pain management tools, expansion of integrative therapies, rising mental health awareness. Major trends in the forecast period include rising use of symptom-based drug therapies, increased adoption of multimodal treatment approaches, growing focus on chronic pain management, expansion of non-pharmacological therapies, improved patient-centered care models.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

What Market Drivers Are Helping Shape The Fibromyalgia Treatment Market Expansion?

An expanding elderly demographic is anticipated to fuel expansion within the fibromyalgia treatment market. This demographic trend signifies an increasing share of older individuals within a given society or group. Fibromyalgia interventions are especially beneficial for the older demographic as they are more prone to developing the condition and frequently face exacerbated symptoms due to factors associated with age. As an illustration, Age UK, a UK-registered charity, reported that in 2023, England had 11 million individuals aged over 65. This number is forecast to rise by 10% over the subsequent five years and by 32% by 2043, representing 1.1 and 3.5 million people, respectively. Furthermore, the 85+ age group, which is the most probable demographic to require health and care provisions, is expected to grow quickly, showing an increase of 8.2% in the next five years and 62.7% by 2043, accounting for 126,000 and 956,000 people, respectively. Consequently, the expanding aging population acts as a catalyst for the expansion of the fibromyalgia treatment market.

How Is The Fibromyalgia Treatment Market Structured Across Different Market Segments?

The fibromyalgia treatment market covered in this report is segmented –

1) By Type: Symptomatic Treatment, Targeted Treatment

2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

What Trends Are Influencing The Fibromyalgia Treatment Market?

Leading companies in the fibromyalgia treatment market are prioritizing the development of technologically advanced solutions, such as computerized behavioral therapy devices, to achieve a competitive edge. These devices are software-based prescription treatments that deliver structured psychological interventions, including Acceptance and Commitment Therapy (ACT), via a digital platform. For example, in May 2023, Swing Therapeutics, a U.S.-based digital therapeutics company, secured FDA De Novo authorization for Stanza. This prescription smartphone-based digital therapy offers a 12-week self-guided ACT program, which demonstrated significant improvements in pain, fatigue, sleep, and mood during its pivotal PROSPER-FM Phase 3 trial. Stanza is made available through Swing Care, a virtual specialty clinic integrating prescription digital therapy with comprehensive fibromyalgia management. This trend not only enhances patient access and reduces reliance on pharmacologic treatments but also aligns with guideline-driven non-drug care, although challenges remain in scaling reimbursement and clinician adoption.

Which Companies Form The Competitive Landscape Of The Fibromyalgia Treatment Market?

Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Endo International plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited, Tonix Pharmaceuticals, Allergan plc, Aptinyx Inc., Novartis AG, Merck & Co Inc.

Access The Complete Fibromyalgia Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

Which Geographic Region Represents The Largest Fibromyalgia Treatment Market Share?

North America was the largest region in the fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibromyalgia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Fibromyalgia Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2026, By The Business Research Company

Neuralgia Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Muscle Pain Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Neurofibromatosis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795